GlassScriptPhysician profile
George Corvin
NPI 1710070982
$866.29
in general payments reported to CMS, 2019-2025
16 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical Forensic Psychiatry provider received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.23 · 2022: $197 · 2023: $320 · 2024: $119 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $352.41 | 2022-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $86.51 | 2019-2022 | |
| Abbvie INC. | $73.26 | 2023-2025 | Vraylar |
| Alkermes, INC. | $43.79 | 2022-2025 | Aristada, Lybalvi |
| Corium, LLC | $41.47 | 2023-2024 | Azstarys |
| Neos Therapeutics, LP | $34.19 | 2019-2022 | |
| Almatica Pharma LLC | $33.66 | 2024 | Loreev Xr |
| Tris Pharma INC | $33.50 | 2022-2025 | Dyanavel Xr |
| Teva Pharmaceuticals USA, INC. | $32.44 | 2022-2023 | Austedo Xr |
| Neurocrine Biosciences, INC. | $22.93 | 2022 | |
| Ironshore Pharmaceuticals INC. | $22.83 | 2024 | |
| Collegium Pharmaceutical, INC. | $21.83 | 2025 | Jornay Pm |
| Brainsway USA INC | $19.21 | 2023 | |
| Vanda Pharmaceuticals INC. | $18.56 | 2025 | Fanapt, Hetlioz |
| Axsome Therapeutics, INC. | $18.03 | 2023 | Sunosi |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Corvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.